The state of Tennessee currently has 15 active clinical trials seeking participants for COVID19 research studies. These trials are conducted in various cities, including Nashville, Memphis, Knoxville and Chattanooga.
Cardiovascular Autonomic and Immune Mechanism of Post COVID-19 Tachycardia Syndrome
Recruiting
The term post-acute COVID-19 syndrome or Long COVID is a disabling syndrome that persists beyond the 3-month convalescence period after COVID-19 infections. This syndrome affects mostly women (~80%), present with chronic tachycardia and Orthostatic intolerance symptoms without any identifiable cause. In addition, non-specific symptoms such as fatigue, headache, and "brain fog", commonly described in POTS patients are also present in this novel condition, recently named post-COVID-19 tachycardia... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
08/18/2023
Locations: Vanderbilt University Medical Center, Nashville, Tennessee
Conditions: Post-acute COVID-19 Syndrome, Postural Tachycardia Syndrome (POTS), Long COVID, SARS CoV 2 Infection
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
Recruiting
This study will seek to enroll immunocompromised patients with Lower Tract parainfluenza infection. It also contains a sub-study to enroll patients with severe COVID-19.
Gender:
All
Ages:
All
Trial Updated:
07/19/2023
Locations: Vanderbilt University Medical Center, Nashville, Tennessee
Conditions: Lower Respiratory Tract Infection, Parainfluenza, Immunocompromised, COVID-19
Elderberry for Immune Support
Recruiting
The purpose of this study is to confirm and quantify the effects of ElderCraft® elderberry extract on immune health.
Gender:
All
Ages:
Between 20 years and 65 years
Trial Updated:
10/10/2022
Locations: Franklin Health Research Center, Franklin, Tennessee
Conditions: Upper Respiratory Tract Infection, COVID-19, Flu, Flu Like Illness, Cold